Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
494 participants
INTERVENTIONAL
2008-05-21
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Smokers with varying levels of health literacy as assessed by the S-TOFHLA (i.e., inadequate, marginal, adequate) recruited from the community will listen to one of 4 different types of messages emphasizing the health consequences of smoking recorded on a computer in the form of audio scripts (i.e., a human voice pre-recorded on a computer will read each message). Messages written at a 5th to 6th grade reading level will be concurrently presented in written form via a computer monitor and be manipulated in terms of 1) emotionality (i.e., primarily fact- vs. primarily emotion-based), and 2) framing (i.e., gain-framed messages that highlight the potential benefits of quitting smoking vs. loss-framed messages that emphasize the potential costs of failing to quit smoking). Emotionality and framing will be completely crossed to create four different types of messages, 1) factual gain-framed (FGF), 2) factual loss-framed (FLF), 3) emotional gain-framed (EGF), and 4) emotional loss-framed (ELF).
The primary objectives are to:
1. Examine whether main effects emerge for health literacy as assessed by the S-TOFHLA (inadequate, marginal, adequate) and the different message types (fact- vs. emotion-based and gain- vs. loss-framed) on the primary explicit and implicit outcomes: a) intention to quit, and b) implicit and explicit attitudes toward smoking.
2. Examine whether health literacy interacts with the different types of messages (fact-based vs. emotion-based and gain-framed vs. loss-framed) to influence the primary explicit and implicit outcome measures: a) intention to quit smoking, and b) implicit and explicit attitudes toward smoking.
A secondary, exploratory aim is to:
3. Examine potential associations between a) the primary explicit and implicit outcomes, and b) the secondary explicit and implicit outcomes: knowledge, risk perception, attitudes, self-efficacy, message evaluations, implicit fear of disease, and implicit associations between smoking and disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Communications for Adults Smoking Nondaily
NCT07296848
STORIES-Stories to Communicate Risk About Tobacco
NCT00101491
Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II
NCT02942212
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
NCT05008848
SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups
NCT05029362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If you agree to take part in this study, you will be asked to complete some questionnaires. The questionnaires will ask about your age, income level, education level, and smoking history. This information will allow researchers to look at whether these factors affect how people understand smoking health risk information. The questionnaires will take about 15 minutes to complete. You will also complete a breath test. To complete the breath test, you will blow into a tube that's attached to a machine about the size of a pocket computer. The breath test is used to estimate the amount of tobacco smoke that you inhale.
You will participate in a focus group. During the focus group, research staff will be present to help discuss and evaluate various smoking risk informational messages. You will be asked to decide which messages may be most influential in terms of helping smokers to quit smoking. The messages will include information about health risks of smoking, such as smoking-related cancers, heart disease, lung disease, gum disease, fertility problems, and other related topics.
The focus group session should last about 1 hour and 30 minutes.
The messages will then be selected by the study doctor and used to create pamphlets on the risks of smoking. These pamphlets will be used to help people quit smoking.
Your participation on this study will be over once you have finished taking part in the focus group. All focus groups will be audiotaped and the tape will be sent to an outside company to be transcribed. No information that could be used to identify you such as your name or date of birth will be provided to the outside company.
This is an investigational study. Up to 30 smokers will participate in the focus groups. All will be enrolled at M. D. Anderson.
Pilot Testing and Main Study:
Many people can get and understand smoking health risk information. This study will look at which types of smoking risk information may be most easily understood by different people. Participants in this study will be asked to listen to and read 1 of 4 types of messages on a computer. These messages will talk about and list some health consequences of smoking.
If you agree to take part in this study, you will be asked to complete several questionnaires. These questionnaires will ask about your feelings and moods, thoughts about smoking, risks of smoking, smoking history, and basic information, such as your age, education level, and income level. The questionnaires will take about 30 minutes to complete. You will also complete a breath test. To complete the breath test, you will blow into a tube that's attached to a machine about the size of a pocket computer. The breath test is used to estimate the amount of tobacco smoke that you inhale.
After you have completed these questionnaires and the breath test, you will complete several computer-aided tasks. These computer-aided tasks will allow you to be able to read and hear informational messages about health risks of smoking, such as smoking-related cancers, heart disease, lung disease, gum disease, fertility problems, and other related topics. During this study visit, you will also evaluate several recently designed informational messages on the health risks of smoking. The computer-aided tasks and the evaluation should last about 30 minutes.
After evaluating these messages, you will be asked to complete additional questionnaires in order for researchers to evaluate your responses to them. These questionnaires will ask your opinion about the informational messages and the risks of smoking. These last set of questionnaires should take about 30 minutes to complete. Your participation will be over in this study once you complete the last set of questionnaires.
This is an investigational study. Up to 420 smokers will participate in this part of the study. All will be enrolled at M. D. Anderson.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Factual Gain-Framed
Smoking Risk Message - Factual Gain-Framed (FGF)
Focus Group
Focus group discussion and evaluation of various smoking risk informational messages. The focus group session should last about 1 hour and 30 minutes.
Questionnaire
Questionnaires taking 15-30 minutes to complete.
Factual Loss-Framed
Smoking Risk Message - Factual Loss-Framed (FLF)
Focus Group
Focus group discussion and evaluation of various smoking risk informational messages. The focus group session should last about 1 hour and 30 minutes.
Questionnaire
Questionnaires taking 15-30 minutes to complete.
Emotional Gain-Framed
Smoking Risk Message - Emotional Gain-Framed (EGF)
Focus Group
Focus group discussion and evaluation of various smoking risk informational messages. The focus group session should last about 1 hour and 30 minutes.
Questionnaire
Questionnaires taking 15-30 minutes to complete.
Emotional Loss-Framed
Smoking Risk Message - Emotional Loss-Framed (ELF)
Focus Group
Focus group discussion and evaluation of various smoking risk informational messages. The focus group session should last about 1 hour and 30 minutes.
Questionnaire
Questionnaires taking 15-30 minutes to complete.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus Group
Focus group discussion and evaluation of various smoking risk informational messages. The focus group session should last about 1 hour and 30 minutes.
Questionnaire
Questionnaires taking 15-30 minutes to complete.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. current smoker with a history of at least 5 cigarettes/day for the last year
3. can speak, read, and write in English
4. home address and a functioning home telephone number
Exclusion Criteria
2. current enrollment in a smoking cessation treatment program
3. expired CO\<10 ppm
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lorna H. McNeill, MPH,PHD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2015-00727
Identifier Type: REGISTRY
Identifier Source: secondary_id
2006-0699
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.